iShares Neuroscience and Healthcare ETF Holdings
IBRNETF · NYSE Arca
$33.30
+$0.01 (+0.02%)
EOD Oct 30, 2026
IBRN holds 68 stocks and 23 other positions (cash and equivalents, derivatives). The largest is Biogen Inc. at 5.17%, and the ten largest make up 41.6% of assets. Holdings as of Oct 28, 2026.
Quality of what it owns
40Stock weight by each holding's Quality score
Dividend strength of what it owns
1Stock weight by each holding's Dividend score: five years of payments, payout ratio, growth
All 68 stocks
Weight as a share of the fund's assets, Oct 28, 2026
| # | Company | Sector | ||||
|---|---|---|---|---|---|---|
| 1 | Healthcare | 5.17% | n/a | 39 | 0 | |
| 2 | Healthcare | 4.59% | n/a | 40 | 0 | |
| 3 | Healthcare | 4.39% | n/a | n/a | 0 | |
| 4 | Healthcare | 4.37% | n/a | 82 | 0 | |
| 5 | Healthcare | 4.25% | n/a | 65 | 0 | |
| 6 | Healthcare | 4.04% | n/a | 67 | 0 | |
| 7 | Healthcare | 3.80% | n/a | 61 | 0 | |
| 8 | Healthcare | 3.79% | n/a | 10 | 0 | |
| 9 | Healthcare | 3.65% | n/a | 10 | 0 | |
| 10 | Healthcare | 3.56% | n/a | 10 | 0 | |
| 11 | Healthcare | 3.39% | n/a | 77 | 0 | |
| 12 | Healthcare | 3.30% | n/a | 40 | 0 | |
| 13 | Healthcare | 3.27% | n/a | n/a | 0 | |
| 14 | SKSk Biopharmaceuticals Ltd326030 | Health Care | 3.25% | n/a | n/a | n/a |
| 15 | HH. Lundbeck Class BHLUN B | Health Care | 3.11% | n/a | n/a | n/a |
| 16 | Healthcare | 2.94% | n/a | n/a | 0 | |
| 17 | Healthcare | 2.88% | n/a | 51 | 0 | |
| 18 | Healthcare | 2.84% | n/a | 10 | 0 | |
| 19 | NENeuren PharmaceuticalsNEU | Health Care | 2.16% | n/a | n/a | n/a |
| 20 | BIBioarctic Class BBIOA B | Health Care | 2.04% | n/a | n/a | n/a |
| 21 | ONOncolys Biopharma Inc4588 | Health Care | 1.89% | n/a | n/a | n/a |
| 22 | Healthcare | 1.65% | n/a | 40 | 0 | |
| 23 | Healthcare | 1.55% | n/a | n/a | 0 | |
| 24 | Healthcare | 1.53% | n/a | 30 | 0 | |
| 25 | RURubicon ResearchRUBICON | Health Care | 1.25% | n/a | n/a | n/a |
Other positions (23)
Part of the fund's official holdings list, but not companies: cash, money market funds, futures and the like.
| Position | Type | Weight |
|---|---|---|
| Sk Biopharmaceuticals Ltd | Stock | 3.25% |
| H. Lundbeck Class B | Stock | 3.11% |
| Neuren Pharmaceuticals | Stock | 2.16% |
| Bioarctic Class B | Stock | 2.04% |
| Oncolys Biopharma Inc | Stock | 1.89% |
| Rubicon Research | Stock | 1.25% |
| Metis Techbio Class H | Stock | 0.54% |
| Sanbio Ltd | Stock | 0.53% |
| Zylox-Tonbridge Medical Tech H | Stock | 0.49% |
| Microport Neurotech Corp | Stock | 0.35% |
| Newron Pharmaceuticals | Stock | 0.28% |
| Blk Csh Fnd Treasury Sl Agency | Cash and equivalents | 0.09% |
| Cash Collateral Usd Sgaft | Cash and equivalents | 0.03% |
| Aud Cash | Cash and equivalents | 0.02% |
| Krw Cash | Cash and equivalents | 0.01% |
| Jpy Cash | Cash and equivalents | 0.01% |
| Eur Cash | Cash and equivalents | 0.01% |
| Chf Cash | Cash and equivalents | 0.00% |
| Dkk Cash | Cash and equivalents | 0.00% |
| Hkd Cash | Cash and equivalents | 0.00% |
| Sek Cash | Cash and equivalents | 0.00% |
| Micro E-Mini Russell 2000 Dec 26 | Derivative | 0.00% |
| Usd Cash | Cash and equivalents | -0.01% |
Concentration
How much of the fund sits in its largest stocks
IBRN holdings questions
How many stocks does IBRN hold?+
68 stocks as of Oct 28, 2026, plus 23 cash or money-market lines worth 0.18% of assets.
What is IBRN's largest holding?+
Biogen Inc. (BIIB) at 5.17% of the fund. The ten largest positions add up to 41.6%.
Which sectors does IBRN invest in most?+
Healthcare (83.9%), Health Care (15.9%).
How often does IBRN change its holdings?+
In its last fiscal year the fund's turnover was 46%. Weights move every day with prices, so this list shows the weights on Oct 28, 2026.
Holdings: the fund's own holdings list, published by BlackRock iShares, as of Oct 28, 2026. Checked against the fund's SEC Form N-PORT for Jul 31, 2026: 50 of these 68 stocks are in that filing too (the rest changed through trading since, such as the index's yearly rebalance). Quality and Dividend scores and yields: computed by Intrinsiqq from each company's SEC filings and today's price.